BioCatalyst

Leniolisib — catalyst calendar

2 verified catalyst event(s) referencing Leniolisib, each linked to its official source. Verified as of 2026-09-20.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-11 (month)
in 1mo
ESTIMATED
 READOUT
Leniolisib for Immune Dysregulation in PIDs
Phase 2 · Primary Immunodeficiency Disorders (PIDs)
 Pharming Technologies B.V. Leniolisib ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
2026-11-30
in 2mo
ESTIMATED
 READOUT
Pediatric Patients Aged 4 to 11 Years With APDS
Phase 3 · APDS
 Pharming Technologies B.V. Leniolisib ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.